THE MEDICAL CLINICS OF NORTH AMERICA Med Clin N Am 87 (2003) 1263-1305 Cumulative Index 2003 Volume 87 January PREOPERATIVE MEDICAL CONSULTATION, pages 1-302 March THERAPEUTIC OPTIONS IN HEART FAILURE, pages 303-588 May CASE STUDIES IN NEUROLOGY, PART I, pages 589-754 July CASE STUDIES IN NEUROLOGY, PART II, pages 755-916 September WOMEN’S HEALTH ISSUES, pages 917-1156 November CONTEMPORARY THROMBOSIS DEBATES, pages 1157-1306 Note: Page numbers of article titles are in boldface type. A Adenoviruses, as get e transfer vectors, A-127722 (endothelin receptor antagonist), for CHF, 555, 555 7 myocardial remodeling and, 469 Adhesion molecules, in CHF, 308, 313 Abdominal pain, in porphyria, 718 Adolescents, HIV infection in, 992 ACE inhibitors. See Angiotensin-converting Adrenal gland dysfunction, perioperative, enzyme inhibitors. 54 Acetaminophen, for migraine headache, in cancer chemotherapy, 251-252 594 Adrenergic system gene polymorphisms, Acetazolamide, for Meniere’s disease, CHF pharmacogenomics and, 636-637 571-573 Acetylcholine, impaired action of, in CHF, Advanced sleep phase syndrome, 444 822-823 Acorn cardiac support device, for CHF, Advocacy, multicultural aspects of, 952 545-546 African American women Acoustic neuroma, dizziness in, 614-615 health facts about, 943-945 hot flashes in, 1094-1095 Acquired immunodeficiency syndrome. See Human immunodeficiency Age factors virus infection. in beta-blocker action, in CHF, 355 in perioperative thromboembolism Actigraphy, in sleep disorders, 809 risk, 79 Acupuncture, for hot flashes, 1108 Agency for Health Care Policy and Acute retroviral syndrome, in women, Research, minority women’s health 974-975 data from, 947 Acyclovir AIDS. See Human immunodeficiency virus for Bell’s palsy, 702 infection. for herpes zoster, 699 Airway obstruction, in cancer, Adeno-associated virus, as gene transfer perioperative, 245-246 vector, for CHF, 556 Alaskan native women, health facts about, Adenosine receptor antagonists, for CHF, 946-947 481-482 Albumin, preoperative measurement of, 24 0025-7125/03/$ - see front matter © 2003 Elsevier Inc. All rights reserved. doi: 10.1016/S0025-7125(03)00161-5 1264 Cumulative Index |M ed Clin N Am 87 (2003) 1263-1305 Alcohol consumption American College of Physicians, cardiovascular risk and, in diabetes preoperative cardiac assessment mellitus, 960 guidelines of, 122 sensory neuropathy in, 695-698 American Heart Association Alcoholic liver disease, perioperative, 213 cardiac risk classification of, 112-116 preoperative cardiac assessment Aldactone. See Spironolactone. guidelines of, 119-122 Aldosterone, CHF and, 441-457 American Indian women, health facts pathophysiologic aspects of, 443-447, about, 946—947 482-484 Randomized Aldactone Evaluation American Sleep Disorders Association, Study of, 442 sleep disorder classification of, receptor antagonists for, 442, 447-453, 831-833 482-485 American Surgical Association, cardiac risk significance of, 441-442 classification of, 112 Aldosterone receptor antagonists, for CHF, 482-485 Amidolytic assay, for protein C, 1240-1241 clinical studies of, 442 Amiloride, for CHF, 479 indications for, 449-450 mechanisms of action of, 447-449 6-Aminolevulinic acid accumulation, in pathologic basis for, 443-447 porphyria, 717-718 regimen for, 450-451 Amiodarone, perioperative, 42 selective, 451-453, 485 Amitriptyline Aldosterone synthase polymorphisms, CHF for meralgia paresthetica, 706 pharmacogenomics and, 573 for sensory neuropathy, 697-698 Alendronate Amrinone, for CHF, 401 for osteoporosis, 1046, 1048, 1052-1053 Amygdalohippocampectomy, for epilepsy, perioperative, 46 739-740 Allergy, to penicillin, perioperative Amyloid myopathy, 906-907 prophylaxis and, 61-62 Anaritide, for acute kidney failure, 198 Almotriptan, for migraine headache, Anemia, perioperative, 229-235 594-595 evaluation of, 229-230 Alpha-adrenergic agonists, for hot flashes, in cardiovascular disease, 232—233 1106-1107 in kidney failure, 203-204 in thalassemia, 233 Alpha-adrenergic receptors, in CHF, 393 pathophysiology of, 230-231 Alpha-blockers, for pheochromocytoma, preoperative detection in, 9-11 perioperative, 183-186 sickle cell, 233 transfusions for, 231—235 Alprazolam, for psychogenic dizziness, 636 Anesthesia in cancer, cardiopulmonary Alternative therapies, perioperative, 48-49 obstruction and, 245-246 in coronary artery disease, 130 Ambulation, early, for thromboembolism in kidney failure, 205 prophylaxis, 83, 85 in liver disease, 217 American College of Cardiology respiratory complications and, cardiac risk classification of, 160-161 112-116 Aneurysm preoperative cardiac assessment brain, perioperative, 263-264 guidelines of, 119-122 left ventricular, in CHF, surgery for, American College of Chest Physicians, 529-530 venous thromboembolism risk Angiography stratification criteria of, 82-83 in carotid artery stenosis, 759 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 magnetic resonance, in brainstem Anticoagulants stroke, 613 before colonoscopy, with existing deep venous thrombosis, Angioplasty 1205-1214 carotid, 760-761 for calf deep venous thrombosis, coronary, preoperative, 129-130 1157-1164 Angiotensin-converting enzyme inhibitors antagonist’s perspective on, for CHF, 373-381,484 485 1160-1162 beta-blocker interactions with, protagonist's perspective on, 355 1157-1160 clinical trials of, 375-381 for cerebral venous thrombosis, cough in, 573 765-767 mechanisms of action of, 376-377 for chronic inferior venal caval filter, pharmacogenomics of, 570-571, 1189-1203 573 antagonist’s perspective on, prophylactic, 378-379 1192-1201 treatment objectives and, protagonist's perspective on, 374-376 1189-1191 uncertainties with, 373, 379-381 for iliofemoral deep venous versus digoxin, 327 thrombosis, 1166, 1168-1169 for hypertension, perioperative, 140 perioperative, 44-47, 96-100 for transient ischemic attack, 758 in brain tumors, 1179-1187 in valvular heart disease, 149 Angiotensin II, in CHF, 310 Anticytokines, for CHF, 419-440 Angiotensin receptor blockers, for CHF, animal studies of, 422-428 381-385, 429 failure of, 431-434 Ankle human studies of, 426, 429-434 pain in, in tarsal tunnel syndrome, pathophysioiogy and, 421-422 682-685 Antidepressants weakness of, in peroneal neuropathy, for cataplexy, 816 at fibular neck, 677-679 for hot flashes, 1103-1105 Anorexia, in congestive heart failure, 304 for meralgia paresthetica, 706 for sensory neuropathy, 697-698 Antiarrhythmic agents, perioperative, perioperative, 50-51 42-43, 145-146 Antidiuretic hormone, inappropriate Antibiotic prophylaxis, perioperative, secretion of, perioperative, 59-75 246-247, 268-269 for endocarditis, 67—70 for surgical site infections, 59-67 Antidiuretic hormone receptor benefits of, 61 antagonists, for CHF, 480-481 duration of, 62 Antiepileptic drugs. in cardiac surgery, 63-64 See alsospecific drugs. in gastrointestinal procedures, advantages of, 741 63-64 breast milk transmission of, 731 gynecologic surgery, 63-66 disadvantages of, 741 head and neck surgery, 65-66 for medically resistant partial-onset neurologic surgery, 65-66 epilepsy, 738-740 ophthalmic procedures, 65-66 for new-onset epilepsy, 727-728 orthopedic procedures, 65-67 in elderly persons, 732-735 in penicillin allergy, 61-62 in mental retardation, 735-738 in thoracic procedures, 65, 67 noncompliance with, 740-741 in urologic procedures, 67 oral contraceptive interactions with, in vascular procedures, 65, 67 729-730 postoperative, 59-61 side effects of, 728 principles of, 61-62 teratogenesis due to, 730-731 risks of, 60-61 vs. nonantimicrobial strategies, Antihypertensive agents, perioperative, 60-61 43, 139-141 1266 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 Antiparkinsonian agents, perioperative, for thromboembolism 49-50 prophylaxis, 88-89 Antiphospholipid antibodies, testing for, Asthma 1240-1241 CHF with, beta-blockers contraindicated in, 359 Antiplatelet agents, perioperative, 44-46 drugs for, perioperative, 43-44 Antipsychotic agents, perioperative, 52 Atasia without abasia, 800 Antiretroviral agents Ataxia, spinal cerebellar, gait in, 797-798 for HIV infection, in women, 987-991, 993 Atenolol perioperative, 48 for coronary artery disease, perioperative, 127 Antiseizure agents, perioperative, 50 for reflex syncope, 846 Antithrombin defects, testing for, Atherosclerosis, carotid, 759-761 1239-1241, 1243, 1247-1248 Atrial fibrillation Anxiety, dizziness in, 634-636 in CHF, beta-blocker effects on, 349, Anxiolytics, perioperative, 53 354 perioperative, 143-145 Aortic regurgitation venous thromboembolism and, heart failure in, treatment of, 396 98-99 perioperative, 148 Atrial natriuretic peptide Aortic stenosis description of, 485-486 heart failure in, treatment of, 396 for acute kidney failure, 198 perioperative, 147-148 for CHF, 476-477, 486-487 APC resistance assay, for factor V Leiden, Atrioventricular block, in CHF, 1240 beta-blockers contraindicated in, 360 Apnea, sleep. See Sleep apnea. Atrioventricular node, digoxin effects on, Apnea-hypopnea index, 812 321 Apoptosis, of myocytes, in CHF, 308 Attention-deficit/hyperactivity disorder, gene therapy for, 559-560 Tourette’s syndrome and, 773 Aquaretic agents, for CHF, 480-485 Auerbach/Goldman algorithm, for preoperative assessment, in coronary Arginine vasopressin receptor antagonists, artery disease, 130-132 for CHF, 480-481 Autoimmune disease, gender differences in, Arousal disorders, 824-825, 831 931 Arrhythmias, cardiac Autonomic nervous system digoxin-induced, 321, 332-333 digoxin effects on, 319, 321-324 perioperative, 143-147 dysfunction of resynchronization for. See Cardiac acute and subacute, resynchronization therapy. orthostatic hypotension in, 852-854 Arteriolar resistance, in CHF, 476 chronic, orthostatic hypotension Arteritis, temporal, headache in, 602-604 in, 849-852 in migraine headache, 591 Arthritis, sexual activity after, 1083 testing of, in orthostatic hypotension, Ascites, perioperative, 216-217 854-855 Asian and Asian Pacific Islander women Axilla, radial nerve compression at, health facts about, 945-946 671-673 hot flashes in, 1094 Axillary node biopsy, in breasi cancer, Aspirin 1020-1021 for migraine headache, 594 perioperative, 44-45 Azathioprine, for multiple sclerosis, 881 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 1267 B advanced, in drug combinations, 410 B lymphocytes, infiltration of, in multiple sclerosis, 869-870 bradycardia management with, 363 Back pain, 641-660 clinical trials of, 342-348 anatomic considerations in, 643-645 age factors in, 355 epidemiology of, 642 agents studied, 342-343 evaluation of, 641 BEST, 344, 346-347, in osteomyelitis, 649-650 350-351, 354-355 in spinal stenosis beta-blocker differences in, foot drop in, 656-658 356-357 numbness in, 652-654 CAPRICORN, 344, 346, localized, 645-646 348, 350-352 nonradiating, conservative treatment CARMEN, 345 of, 647-648 CHRISTMAS, 345 pathophysiology of, 645-647 CIBIS-II, 344, 346-347, physical examination in, 647 354, 356 radicular, 647 COMET, 344, 352 referred, 647 COPERNICUS, 344, risk factors for, 642-643 346-348, 351-352, 354-356, 358 Baclofen for spasticity, in multiple sclerosis, drug interactions in, 355 885-886 ethnic factors in, 355 for trigeminal neuralgia, 711 in atrial fibrillation, 354 in diabetes mellitus, 355 Bacteremia, prophylaxis for, perioperative, MERIT-HF, 344, 346-347, 67-70 MOCHA, 357-358 Bacterial vaginosis, in HIV infection, 976-977 morbidity effects in, 349-350 Balance disorders. See Gait disorders. mortality effects in, 350-352 patient types studied, 343 Baroreceptors, carotid remaining issues in, 357-358 digoxin effects on, 319, 323-324 SENIORS, 344 in CHF, 476-477 severe, 354 Barr bodies, 926 subgroup analysis of, 353-355 Batista operation, for CHF, 534-539 symptom effects of, 348 Behavioral modification tolerability in, 352-353 for hot flashes, 1108-1109 U.S. Carvedilol Trial for osteoporosis, 1049 Program, 343-344, 346, 351-352 Bellergal, for hot flashes, 1106 ventricular function effects Bell’s palsy, 700-703 in, 349 versus heart failure etiology, Belmont Report, 920 354 contraindications to, 359-361 Benediction posture, in ulnar neuropathy dose for, 362 at elbow, 665 drug selection in, 361 Benign paroxysmal vertigo, 623-627 hypotension management with, 362-363 Benzodiazepines, perioperative, 53 in asymptomatic left ventricular in kidney failure, 205 dysfunction, 359 Beta-adrenergic activity, in CHF, 306-310 initiation of, 361-362 as gene transfer target, 560-561 mechanisms of action of, 340-342 sympathomimetics and, 392-401 myths concerning, 339-340 patient selection for, 358-359 Beta-blockers pharmacogenomics of, 355, for CHF, 314, 339-371 571-573 1268 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 Beta-blockers (continued) Blood pressure, control of, perioperative, recent-onset, 359 139-141 recommendations for, 358-359 in kidney failure, 204 side effects of, 362-365 in neurologic disease, 266-267 stabilization with nonglycoside Blood vessels, aldosterone effects on, inotropic agents before, 412 444-447 tumor necrosis factor-% levels and, 429 BMS-193884 (endothelin receptor worsening heart failure during, antagonist), for CHF, 468 363-364 for migraine headache, 596 Bone for reflex syncope, 846 gender differences in, 926-927 perioperative remodeling of, 1040-1041 for arrhythmias, 145 Bone loss, in multiple sclerosis, 890 for cardiac disorders, 42 for coronary artery disease, Bone mass density, in osteoporosis 126-128 measurement of, 1041-1042, 1045 for hypertension, 140 monitoring of, 1056-1057 for pheochromocytoma, parathyroid hormone effects on, 184-185 1054-1055 raloxifene effects on, 1051 Biopsy in breast cancer, 1005-1007 Bosentan temporal artery, in headache, 604 for CHF, 465, 467 for kidney failure, 465 Bisoprolol for CHF, clinical trials of Botulinum toxin CIBIS-II, 344, 346-347, 354, 356 for dystonia, 776-777 mortality effects in, 350-351 for spasticity, in multiple sclerosis, 886 versus heart failure etiology, 354 Bowel dysfunction, in multiple sclerosis, 888 versus other beta-blockers, 356 with atrial fibrillation, 354 BQ-123 (endothelin receptor antagonist), for coronary artery disease, for CHF, 466-467, 469 perioperative, 126-127 BQ-788 (endothelin receptor antagonist), Bisphosphonates, for osteoporosis, 1046. for CHF, 466-467 1048, 1052-1053 Brachial plexopathy, 714-716 Biventricular pacemaker, for CHF, Brachytherapy, for breast cancer, 1022 501-502 Bradbury-Eggleston syndrome, orthostatic Black cohosh, for hot flashes, 1101-1103 hypotension in, 854 Bladder dysfunction Bradyarrhythmias, perioperative, 146 in menopause, 1030-1032 in multiple sclerosis, 886-888 Bradycardia in CHF Bleeding beta-blockers contraindicated in, perioperative, 235-239 360 in brain tumors, 1184-1185 in beta-blocker therapy, in kidney failure, 203-204 management of, 363 in liver disease, 216 in neurally mediated syncope, 837, 840 risk factors for, 82-83, 96-98 in seizures, 848 risk of in anticoagulant therapy for calf Bradykinin receptor gene polymorphisms, deep vein thrombosis, CHF pharmacogenomics and, 573 1157-1158, 1162 Brain in bridging therapy with heparin, 1211 aneurysm of, perioperative management in, 263-264 in thrombolytic therapy, 1171-1172 gender differences in, 928-929 injury of, hypersomnia after, 817 Blood gas analysis, preoperative, 163 lobar hemorrhage of, 764-767 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 1269 tumors of Bugbane, for hot flashes, 1101—1103 perioperative management in, 264-265 Bumetanide, for CHF, 478-479 thromboprophylaxis for, Bundle branch block, perioperative, 146 1179-1187 Bureau of Primary Health Care’s Office of Brain natriuretic peptide Minority and Women’s Health Care description of, 485-486 Policy and Research, minority for CHF, 410, 476-477, 486-487 women’s health data from, 947 versus dobutamine, 397 Butalbital combination medications, for Brainstem, infarction of, dizziness in, migraine headache, 594 611-614 Butorphanol, for migraine headache, 594 Breast cancer, 997-1028 black cohosh and, 1102 Buttock pain, in piriformis syndrome, diagnosis of, 1004-1007 686-688 biopsy methods for, 1006-1007 Butyrophenones, perioperative, 52 nonpalpable mass evaluation, 1005-1006 C palpable mass evaluation, 1004-1005 C-reactive protein multicultural considerations in, cardiovascular risk from, in diabetes 943-947 mellitus, 961] risk of measurement of, in temporal arteritis, identification of, 1013-1015 604 reduction of, 1008-1012 screening for, 998-1004 C-type natriuretic peptide, 485 magnetic resonance imaging in, Cadherins, in CHF, 313 1004 mammography in, 998-1003 Calcitonin self-examination in, 998 for osteoporosis, 1047-1048, ultrasonography in, 1003-1004 1053-1054 sexual! activity after, 1083 perioperative, 46, 48 treatment of, 1016-1023 Calcium adjuvant systemic therapy in, handling of, as gene transfer target, for 1022-1023 CHF, 556-559 axillary surgery in, 1020-1021 in digoxin action, 319-320 conservative, 1016-1018 supplementation with, for neoadjuvant chemotherapy in. osteoporosi1s0,4 9 1018-1020 radiation therapy in, 1022 Calcium channels, phosphorylation of, in CHF, 308-310 Breast-feeding HIV transmission in, 986-987 Calf, deep venous thrombosis of in epilepsy, 731 anticoagulants for, 1157-1164 antagonist’s perspective on. Breast pain, discussion of, communication 1160-1162 in, 1131-1132 protagonist's perspective on, Breathing disorders, sleep disorders in, 1157-1160 809-814 clinical significance of, 1161 central sleep apnea-hypopnea epidemiology of, 1160 syndrome, 813-814 natural history of, 1158-1159 mixed sleep apnea, 810-812 Canaiiih repositioning, for benign obstructive sleep apnea, 809-812, 821 paroxysmal vertigo, 624-627 Bromocriptine, for CHF, 399-400 Cancer Bucindolol, for CHF breast. See Breast cancer. clinical trials of, BEST, 344, 346-347, cervical, in human papillomavirus 350-351, 354-355 infections, in HIV infection, pharmacogenomics of, 571—572 980-982 1270 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 Cancer (continued) Cardiac glycosides. See also Digoxin. multicultural considerations in, for CHF, 317-318 943-948 Cardiac index, digoxin effects on, 323 paraneoplastic syndromes in acute autonomic neuropathy, 853 Cardiac output sensory neuropathy, 712-713 in congestive heart failure, 304 perioperative management of, 243-256 reduced. cardiovascular risk and, in cardiopulmonary considerations diabetes mellitus, 964 in, 245-246 chemotherapy effects in, 249-252 Cardiac pacing, for reflex syncope, 847 endocrine considerations in, Cardiac procedures, antibiotic prophylaxis 246-247 for, 63-64 hematologic considerations in, 247-248 Cardiac resynchronization therapy, for metabolic considerations in, CHF, 501-502, 509-521 246-247 clinical trials of, 513-518 neurologic considerations in, 249 CARE-HF. 518 nutritional status and, 244 COMPANION, 517-518 pain and, 244-245 CONTAK CD, 517-518 performance status variations MIRACLE, 515-516 and, 244 MIRACLE ICD, 517 radiation therapy effects in, MUSTIC, 515 252-253 PATH-CHF, 514 thromboembolism risk in, 81 historical view of, 509-511 mechanisms of action of, 511-512 Candesartan, for CHF, 385, 429 patient selection for, 518-519 Candidiasis, vulvovaginal, in HIV infection, remodeling in, 513 978-979 CardioClasp”. for CHF, 547 Canrenone, for CHF, 485 Cardiogenic shock, dopamine for, 398-399 Capsaicin, for meralgia paresthetica, 706 Cardiomyopathy dilated, CHF in Captopril, for CHF beta-blocker effects on, 349 pharmacogenomics of, 571 versus digoxin, 326 digoxin effects on, 323 versus losartan, 384-385 surgical treatment of. See Surgery, for CHF. Carbamazepine of overload, in CHF, 307-308 for epilepsy perioperative, 142-143 advantages of, 741 breast milk transmission of, 731 Cardiovascular system. See also Heart. disadvantages of, 741 disorders of headache in, 602-603 in elderly persons, 733 in mental retardation, 735-738 in diabetes mellitus. See Diabetes in pregnancy, 729-731 mellitus, cardiovascular risk new-onset, 728 in. side effects of, 728 multicultural considerations in, for multiple sclerosis, 878 943-947 for sensory neuropathy, 697-698 gender differences in, 927-928 for trigeminal neuralgia, 711 Cardioverter-defibrillator, implantable, Carbidopa-levodopa perioperative management with, 146-147 for Parkinson’s disease, 785-786 for restless legs syndrome, 820 Carnitine, for CHF, 494-495 perioperative, 49-50 Carotid artery(ies), stenosis of, 759-761 Cardiac arrhythmias. See Arrhythmias. Carotid artery disease, perioperative Cardiac catheterization, right heart, management in perioperative, 141-142 in endarterectomy, 261-263 Cardiac drugs, perioperative, 42-43 in general surgery, 258-259 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 Carotid baroreceptors, digoxin effects on, dizziness in, 762-764 319, 323-324 epilepsy in, 732-735 headache in, 764-767 Carotid sinus lobar hemorrhage, 764-767 hypersensitivity of, syncope in, minor stroke, 755—758 841-842 perioperative management in, 25 massage of, in syncope, 845 transient ischemic attack, 755 Carpal tunnel syndrome, 661-664, 706-708 Cervical dystonia, 775-777 Carvedilol, for CHF Cervical intraepithelial neoplasia, in human clinical trials of, 343-348 papillomavirus infections, in HIV age factors in, 355 infection, 980-982 dose for, 357-358 ethnic differences in, 355 Cervicitis, in HIV infection, 979 in severe heart failure, 354 morbidity effects in, 350 Cervix, human papillomavirus infections of, in HIV infection, 980-982 mortality effects in, 350-352 patient selection for, 344, Charcot-Marie-Tooth disease, 703-704, 799 346-348, 351-358 symptom effects of, 348 Chemotherapy, for cancer tolerability in, 352-353 breast versus heart failure etiology, 354 adjuvant systemic, 1022-1023 versus other beta-blockers, neoadjuvant, 1018-1020 356-357 perioperative management of, 249-252 with atrial fibrillation, 354 Chest pain pharmacogenomics of, 577 2-573 discussion of, communication in, 1130-1131 Catamenial seizures, 732 in herpes zoster, 698-700 Cataplexy, in narcolepsy, 814, 816 Chest physical therapy. postoperative. 168 Catecholamines, excess of, in pheochromocytoma, perioperative Chest radiography, preoperative, 28-29, 32-34. 163 management of, 183-186 Catheterization, cardiac, right heart. Cheyne-Stokes breathing, in sleep apnea, 813 perioperative, 141-142 Centers for Disease Control, minority CHF. See Congestive heart failure. women’s health data from, 947 Chlorpromazine, perioperative, 52 Central nervous system. See also Brain. Chlorthalidone, for CHF, 479 gender differences in, 928 929 Cholecystitis, acalculous, postoperative Central positional vertigo, 627-629 jaundice in, 221 Central sleep apnea-hypopnea syndrome, Cholesterol. excess of. cardiovascular risk 813-814 from, in diabetes mellitus, 958-959 Cephalosporins, for postoperative infection Chorea, Huntington's, 788-789 risk reduction, 61-62, 64-65 Chromosomes, sex, in gender-specific Cerebellar artery infarcts, dizziness in, medicine, 925-926 613-614 Chronic fatigue syndrome, versus Cerebellar ataxia, spinal, gait in, 797-798 orthostatic intolerance, 858-859 Cerebral venous thrombosis, 764-767 Chronic obstructive pulmonary disease, Cerebrospinal fluid, drainage of, for normal perioperative management of pressure hydrocephalus, 797 drugs for, 43-44 respiratory complications in, 156 Cerebrovascular disease, 755-770 thromboembolism risk in, 81 acute stroke, 761-762 carotid stenosis, 759-761 Chronotherapy, for sleep disorders, 823 cerebral venous thrombosis, 764-767 Cilostazol, perioperative, 45 1272 Cumulative Index | Med Clin N Am 87 (2003) 1263-1305 Cimicifuga racemosa (black cohosh), for hot in pain discussions, 1128-1132 flashes, 1101-1103 in physical activity counseling, 1126-1128 Circadian rhythm disorders, sleep disorders in terminal illness, 1132-1134 in, 822-823, 831 modalities for, 1136 Cirrhosis, perioperative, 24-25, 213-217 multicultural issues in, 948-951, 1123-1125 Citalopram, perioperative, 51-52 new modalities for, 1116 Claudication, neurogenic, in spinal stenosis, nonverbal, 1117 652-654 setting tone for, 1117-1118 structured interview model for, Clindamycin, for bacterial vaginosis, 977 1118-1121 Clinical studies, historical background of, tools for, 1135-1141 919-922 Complementary medicine, multicultural Clomipramine, for cataplexy, 816 issues in, 950-951 Clonazepam Compression devices, pneumatic, for for REM sleep behavior disorder, 826 thromboembolism prophylaxis, 85-87 for restless legs syndrome, 820 for spinal myoclonus, 778-779 Compressive neuropathy. See Entrapment Clonidine and compressive neuropathy. for hot flashes, 1106-1107 Computed tomography perioperative in epilepsy, 726 for coronary artery disease, 128 in syncope, 46 for hypertension, 43, 140 in transient ischemic attack, 757 Clopidogrel, perioperative, 45 Conduction system Clotting assay, for protein C, 1240-1241 digoxin effects on, 321 disorders of Cluster headache, episodic, 592-593 in CHF, resynchronization for. See Cardiac Coagulation disorders, perioperative, 235-239 resynchronization therapy. perioperative, 143-147 in cancer, 247-248 in liver disease, 216 Confusional arousals, from sleep, 824 Coagulation tests, preoperative, 14-17 Congestive heart failure clinical features of, 303-304 Cognitive dysfunction, in multiple sclerosis, 890 historical description of, 303 pathophysiology of, 303-316 Collagen architectural changes in, 304-305 denaturation of, tumor necrosis factor- fight or flight response in, 306 a in, 424-425 functional response in, 306-314 of blood vessels, aldosterone effects on, historical description of, 303 445-446 impaired pump function in, 304 kidney role in, 475-478 Colonoscopy, with existing deep venous opposing mechanisms in, thrombosis, anticoagulants before, 1205-1214 306-308 overload in, 307-308 Colostomy, sexual activity after, 1083 proliferative abnormalities in, 304-314 Communication, patient-doctor, 1115-1145 surgical treatment methods and, clinical settings for, 1125-1126 524-527 components of, 1116 sympathomimetic action and, cue recognition in, 1117-1118 392-394 gaps in, 1115-1116 perioperative, 81, 141-143 gender differences in, 1121-1123 treatment of health literacy and, 1124-1125 advanced, 410-411 importance of, 1115 adverse effects of, 313-314 in informed consent, 1134-1135